The role of fecal calprotectin and lactoferrin in the diagnosis of necrotizing enterocolitis

Pediatric Critical Care Medicine

Volumn 13, Issue 4, 2012, Pages 452-454

  Selimoglu, Mukadder Ayse ^a   Temel, Ismail ^b   Yildirim, Cigdem ^a   Ozyalin, Fatma ^b   Aktas, Mumtaz ^a   Karabiber, Hamza ^a  

^a Departments of Pediatrics   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

Calprotectin; Fecal; Lactoferrin; Necrotizing enterocolitis

Indexed keywords

CALGRANULIN; LACTOFERRIN;

ARTICLE; BREAST FEEDING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; NEWBORN; PREMATURITY; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; ENTEROCOLITIS, NECROTIZING; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LACTOFERRIN; LEUKOCYTE L1 ANTIGEN COMPLEX; PROSPECTIVE STUDIES;

EID: 84864286622     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3182388ae9     Document Type: Article

References (13)

1. Petrosyan M, Guner YS, Williams M, et al: Current concepts regarding the pathogenesis of necrotizing enterocolitis. Pediatr Surg Int 2009; 25: 309-318
2. Bradshaw WT: Necrotizing enterocolitis: Etiology, presentation, management, and outcomes. J Perinat Neonatal Nurs 2009; 23: 87-94
3. Sutherland AD, Gearry RB, Frizelle FA: Review of fecal biomarkers in inflammatory bowel disease. Dis Colon Rectum 2008; 51: 1283-1291
4. Carroll D, Corfield A, Spicer R, et al: Faecal calprotectin concentrations and diagnosis of necrotising enterocolitis. Lancet2003; 361: 310-311 (Pubitemid 36126194)
5. Angriman I, Scarpa M, D'Inca R, et al: Enzymes in feces: Useful markers of chronic inflammatory bowel disease. Clin Chim Acta 2007; 381: 63-68 (Pubitemid 46719135)
6. Hayakawa T, Jin CX, Ko SB, et al: Lactoferrin in gastrointestinal disease. Intern Med 2009; 48: 1251-1254
7. Joishy M, Davies I, Ahmed M, et al: Fecal calprotectin and lactoferrin as noninvasive markers of pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2009; 48: 48-54
8. Walker TR, Land ML, Kartashov A, et al: Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2007; 44: 414-422 (Pubitemid 46573222)
9. Nissen AC, van Gils CE, Menheere PP, et al: Fecal calprotectin in healthy term and preterm infants. J Pediatr Gastroenterol Nutr 2004; 38: 107-108 (Pubitemid 39274480)
10. Yang Q, Smith PB, Goldberg RN, et al: Dynamic change of fecal calprotectin in very low birth weight infants during the first month of life. Neonatology 2008; 94: 267-271
11. Laforgia N, Baldassarre ME, Pontrelli G, et al: Calprotectin levels in meconium. Acta Paediatr 2003; 92: 463-466 (Pubitemid 37088476)
12. Campeotto F, Baldassarre M, Butel MJ, et al: Fecal calprotectin: Cutoff values for identifying intestinal distress in preterm infants. J Pediatr Gastroenterol Nutr 2009; 48: 507-510
13. Campeotto F, Kalach N, Lapillonne A, et al: Time course of faecal calprotectin in preterm newborns during the first month of life. Acta Paediatr 2007; 96: 1531-1533 (Pubitemid 47416431)